openPR Logo
Press release

Hutchinson-Gilford Progeria Treatment Market - Global Industry Insights, Trends and Opportunity Analysis, 2016-2024

03-22-2017 03:44 PM CET | Health & Medicine

Press release from: Pharmaceutical Report By CMI

Hutchinson-Gilford Progeria Treatment Market - Global

Hutchinson-Gilford progeria syndrome is a genetic condition characterized by the dramatic, rapid, appearance of aging from the childhood. Hutchinson-Gilford progeria syndrome is caused by a mutation in the lamin A (LMNA) gene. The affected children develop a characteristic facial experience including prominent eyes, small chin, protruding ears, thin lips and a thin nose with a beaked tip. This syndrome also causes hair loss (alopecia), joint abnormalities, aged-looking skin, and a loss of fat under the skin (subcutaneous fat). Moreover, patients of Hutchinson-Gilford progeria syndrome experiences severe hardening of the arteries (arteriosclerosis) from the childhood. The condition worsens with age and increases the risk of heart attack or stroke even at a young age.

Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/35

Hutchinson-Gilford progeria is a rare condition that affects about one in four million newborns worldwide according to the National Institutes of Health (NIH). Until now more than 130 cases have been reported as per the NIH statistics. The affected patients live up to 30 years maximum, with an average life span of 13 years. Nearly 90% of the patients die from complications related to atherosclerosis. Till 2012 there wasn’t any effective treatment therapy discovered for Hutchinson-Gilford progeria syndrome. The treatments available focused mostly on reducing cardiovascular symptoms and growth abnormalities.

Farnesyltransferase Inhibitor (FTI)

In 2012, findings of the first clinical trial of the drug Lonafarnib, a farnesyltransferase inhibitor (FTI), gave a new hope for the treatment of children with Hutchinson-Gilford progeria syndrome. Clinical trial results demonstrated improvement in weight gain, increase in bone mineral density, reduced vascular stiffness, and improved sensorineural hearing in patients with progeria. Previous treatments with growth hormone, and Sulforaphane helped in reducing the symptoms, and prolong a child’s life. However, it is essential that the patient regularly visits the cardiologist. Rapamycin is one other drug used before, that demonstrated to reverse nuclear blebbing, retard cellular senescence, and facilitate degradation of progerin.

Request for Complete TOC before buying this exclusive Report by CMI @ https://www.coherentmarketinsights.com/ongoing-insight/toc/35

Recently in 2015, the scientists at the Agency for Science, Technology & Research (A*STAR) successfully established a model of Hutchinson-Gilford progeria syndrome. The study conducted by this organization proposed a model which implies that progerin is linked to telomeres. Progerin induces a reduction in heterochromatin, a tightly packed form of DNA, making telomeres in the cell more fragile and susceptible to damage. The damaged telomeres in turn trigger premature cellular aging. This model is radically different from the one believed earlier – the gene progerin caused the nucleus to be deformed, thereby weakening the ability of cells to divide and proliferate. The altered progerin protein makes the nuclear envelope unstable and progressively damages the nucleus, making cells more likely to die prematurely.

Get Discount for First Time Buyers @ https://www.coherentmarketinsights.com/insight/request-discount/35

Researchers are working to determine how genetic changes further leading to the characteristic features of Hutchinson-Gilford progeria syndrome. Continuous advancement in research with increased understanding of the human aging will provide valuable insights and aid in the treatment of this disease.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hutchinson-Gilford Progeria Treatment Market - Global Industry Insights, Trends and Opportunity Analysis, 2016-2024 here

News-ID: 477482 • Views:

More Releases from Pharmaceutical Report By CMI

Angina Pectoris Treatment Market - Global Industry Insights, 2025
Angina Pectoris Treatment Market - Global Industry Insights, 2025
Angina pectoris is a medical term for chest pain or discomfort, which is caused due to coronary heart disease. Angina pectoris mainly occurs when heart muscle are unable to receive adequate blood. This condition usually occurs when one or more of the heart’s arteries are narrowed or blocked, which is also known as ischemia. Angina pectoris leads to uncomfortable pressure, fullness, squeezing or pain in the center of the chest.
Angina Pectoris Treatment Market - Global Industry Insights 2025
Angina Pectoris Treatment Market - Global Industry Insights 2025
Angina pectoris is a medical term for chest pain or discomfort, which is caused due to coronary heart disease. Angina pectoris mainly occurs when heart muscle are unable to receive adequate blood. This condition usually occurs when one or more of the heart’s arteries are narrowed or blocked, which is also known as ischemia. Angina pectoris leads to uncomfortable pressure, fullness, squeezing or pain in the center of the chest.
Glucagon-Like Peptide-1 (Glp-1) Analogs Market - Global Industry Insights - 2025
Glucagon-Like Peptide-1 (Glp-1) Analogs Market - Global Industry Insights - 2025
Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level. GLP-1 analogs prevents the breakdown of GLP-1, thereby enhancing the glucose depended insulin release, suppresses the glucagon release (which reduces hepatic glucose output), and reduces gastric emptying rate (resulting in weight loss from reduced appetite). GLP-1 analogs do not cause hypoglycemia like other class of anti-diabetic
U.S. Opioids Market to Surpass US$ 18,985.4 Million Threshold by 2024
U.S. Opioids Market to Surpass US$ 18,985.4 Million Threshold by 2024
Opioids Crisis – Public Health Emergency Opioids are the class of drugs that include illicit drugs such as heroin, codeine, fentanyl, meperidine, methadone, morphine, hydrocodone, diphenoxylate, hydromorphone, methylphenidate, oxycodone, and oxymorphone, which are generally prescribed for pain management. Opioids are also prescribed for treatment of cough and diarrhea. According to the survey conducted by Center for Behavioral Health Statistics and Quality (CBHSQ), in 2015, out of 20.5 million about 2 million

All 5 Releases


More Releases for Coherent

Surge In Air Traffic Boosts Demand For Advanced Coherent Radar Systems: Pivotal …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Coherent Radar Market Size Growth Forecast: What to Expect by 2025? In recent times, the coherent radar market has demonstrated potent growth. It is anticipated to expand from $8.18 billion in 2024 to $8.97 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.8%. The historic growth
Coherent Radar Market Analysis and Opportunities 2024
"The Business Research Company recently released a comprehensive report on the Global Coherent Radar Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The coherent radar market size
Optogenetics Market to Witness Stunning Growth | Coherent, Addgene, Bruker
The latest study released on the Global Optogenetics Market by HTF MI Research evaluates market size, trend, and forecast to 2029. The Optogenetics market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players in This
Immobilized Trypsin Market Report 2021 - Coherent Market Insights
Immobilized Trypsin Market is created in this intelligence report. This comprehensive research report is a well-thought-out compilation of detailed market development and growth factors optimizing the path of continued growth in terms of exact product data, strategies, and market share of the leading companies in this particular market. We follow an iterative model of research methodology to formulate the report that helps decision-makers make an informed investment appraisal. Literature research
Bioinformatics Market Outlook Till, 2027 : Coherent Market Insights
The Bioinformatics Market report gives a weighty source to assess the market and other fundamental technicalities identifying with it. The examination unveils the total assessment and veritable parts of the Bioinformatics Market. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report.The trends and expected prospects for the market
AI App Development || Coherent Lab LLP
The IT industry is growing day by day and immense popularity. Nowadays, businesses are in search of better opportunities to make money in more innovative way. Considering the AI (artificial intelligence) in mobile and web app development, we at Coherent Lab LLP focuses on developing practical solutions which streamlines to generate more and more profits and smoothen the operations as well. Situated in the heart of pinkcity, Jaipur, Coherent Lab